Login / Signup

Safety and immunogenicity of booster vaccination and fractional dosing with Ad26.COV2.S or BNT162b2 in Ad26.COV2.S-vaccinated participants.

Catherine RiouJinal N BhimanYashica GangaShobna SawryFrances AyresRichard BagumaSashkia R BallaNtombi S B BenedeMallory BernsteinAsiphe S BesethiSandile CeleCarol CrowtherMrinmayee DharSohair GeyerKatherine GillAlba GrifoniTandile HermanusHaajira KaldineRoanne S KeetonPrudence KgagudiKhadija KhanErica Maxine LazarusJean Le RouxGila LustigMashudu MadzivhandilaSiyabulela Fj MaguguZanele MakhadoNelia P ManamelaQiniso MkhizePaballo MosalaThopisang P MotlouHygon MutavhatsindiNonkululeko B MzindleAnusha NanaRofhiwa NesamariAmkele NgomtiAnathi A NkayiThandeka P NkosiF Millicent A OmondiRavindre PanchiaFaeezah PatelAlessandro SetteUpasna SinghStrauss van GraanElizabeth M VenterAvril WaltersThandeka MoyoSimone I RichardsonSharana MahomedHelen V ReesLinda Gail BekkerGlenda Elisabeth GrayWendy A BurgersAlex SigalPenny L MooreLee Fairlie
Published in: medRxiv : the preprint server for health sciences (2023)
South African Medical Research Council (SAMRC) and South African Department of Health (SA DoH).
Keyphrases
  • respiratory syndrome coronavirus
  • sars cov
  • healthcare
  • public health
  • mental health
  • coronavirus disease
  • health information
  • risk assessment